Brittany D. Spitznagel

机构：Biohaven Pharmaceuticals (United States) · ORCID：0000-0003-4172-4147

发表论文 27 篇 · 总被引 243 次 · h-index 9

代表论文

• VU0606170, a Selective Slack Channels Inhibitor, Decreases Calcium Oscillations in Cultured Cortical Neurons (2020 · ACS Chemical Neuroscience · 被引 54)
• A selective inhibitor of the sperm-specific potassium channel SLO3 impairs human sperm function (2023 · Proceedings of the National Academy of Sciences · 被引 40)
• Discovery and Characterization of VU0529331, a Synthetic Small-Molecule Activator of Homomeric G Protein-Gated, Inwardly Rectifying, Potassium (GIRK) Channels (2018 · ACS Chemical Neuroscience · 被引 27)
• Discovery of Small Molecule KCC2 Potentiators Which Attenuate In Vitro Seizure-Like Activity in Cultured Neurons (2022 · Frontiers in Cell and Developmental Biology · 被引 21)
• Altered EEG, disrupted hippocampal long-term potentiation and neurobehavioral deficits implicate a delirium-like state in a mouse model of sepsis (2022 · Brain Behavior and Immunity · 被引 19)
• Design, synthesis, and biological evaluation of a novel series of 1,2,4-oxadiazole inhibitors of SLACK potassium channels: Identification of in vitro tool VU0935685 (2023 · Bioorganic & Medicinal Chemistry · 被引 15)